Nefecon Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

The modified-release hard capsules are 19 mm, white coated, opaque, and printed with "CAL10 4MG" in black ink.
Each modified-release hard capsule contains budesonide 4 mg.
Excipient(s) with known effect: Each capsule contains 230 mg of sucrose.
Excipients/Inactive Ingredients: Capsule content: Sugar spheres (sucrose and corn starch), Hypromellose, Macrogol, Citric acid monohydrate, Ethylcellulose, Medium chain triglycerides, Oleic acid.
Capsule shell: Hypromellose, Macrogol, Titanium dioxide, Methacrylic acid and methyl methacrylate copolymers, Talc, Dibutyl sebacate.
Printing ink: Shellac, Iron oxide black.

budesonide

Manufacturer:

Everest

Distributor:

FP Healthcare